FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bupropion hydrochloride sustained-release from ScieGen Pharmaceuticals, Inc. (ANDA 206122). This action confirms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder
• Tobacco Use Disorder

Drugs mentioned

• Bupropion hydrochloride sustained-release (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (SR) (BUPROPION HYDROCHLORIDE)